Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer

Summary

The purpose of this study is to find out whether Contrast-Enhanced Mammography/CEM scans performed 2 minutes and 6 minutes after receiving Iohexol contrast dye can be used to identify the amount of residual disease in the breast following neoadjuvant treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Any women >18 years of age at time of informed consent
Diagnosed with breast cancer and schedule for NAT

Exclusion Criteria:

History of kidney disease, creatinine level >1.3 or eGFR <45.
Known allergic reaction to gadolinium or iodinated contrast media.
Contraindication to contrast-enhanced breast MRI.
Lesion not included in the field of view of either pre- or post-NAT MRI or CEM
Presence of pacemakers or automated implantable cardioverter defibrilator
Pregnant women

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Memorial Sloan Kettering at Basking Ridge (All protocol activities)
Basking Ridge New Jersey, 07920, United States More Info